SNSS Financial Facts

License and other revenue: 683K
Total operating expenses: 9.25M
See Full Income Statement

Property and equipment, net: 17K
Cash and cash equivalents: 16.8M
See Full Balance Sheet

Sunesis Pharmaceuticals Inc. (SNSS) Earnings

  |   Expand Research on SNSS
Next EPS Date 3/11/16 *Est. EPS Growth Rate +64.0% *Last Qtr.
Average EPS % Beat Rate +33.2% Revenue Growth Rate -18.0% *Last Qtr.
Average % Move 1-Wk after EPS +0.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/5/15 Q315 -$0.09-$0.15 +$0.06$700K$1.09M N/A Details
7/30/15 Q215 -$0.15-$0.13 -$0.02$854K$1.21M N/A Details
5/5/15 Q115 -$0.13-$0.16 +$0.03$854K$980K N/A Details
3/12/15 Q414 -$0.02-$0.19 +$0.17$896K$1.17M N/A Details
11/10/14 Q314 -$0.25-$0.17 -$0.08$854K$1.97M N/A Details
8/5/14 Q214 -$0.20-$0.17 -$0.03$2M$1.32M N/A Details
5/7/14 Q114 -$0.26-$0.17 -$0.09$2M$1.32M N/A Details
3/6/14 Q413 -$0.15-$0.20 +$0.05$2M$1.37M N/A Details